High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.

Abstract

The Oncologist 2019;24:911–920; first published on November 27, 2018; doi: 10.1634/theoncologist.2018-0382 The authors regret that the Acknowledgments section was omitted in the original publication of this article. The proper acknowledgments are provided here and in the updated online version of the article. Research reported in this publication was supported in part by the Winship Research Informatics Shared Resource of Winship Cancer Institute of Emory University and National Institutes of Health (NIH)/National Cancer Institute under award number P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The data used in the study are derived from a deidentified National Cancer Database (NCDB) file. The NCDB is a joint project of the Commission on Cancer of the American College of Surgeons and the American Cancer Society. The American College of Surgeons and the Commission on Cancer have not verified and are not responsible for the analytic or statistical methodology employed, or the conclusions drawn from these data by the investigator.